Prism AI Therapeutics, Inc., offers an AI-first clinical multi-omic data management and analytics platform that allows biotech companies and health systems to unlock the value of their own data and create the next generation of drugs and biomarkers. Backed by partnerships with pharmaceutical and diagnostic companies, and with a clear mission to accelerate the development and implementation of precision therapeutics, we are poised to make a significant impact.

The ability to detect and target complex multi-omic differential signatures is the basis for personalized medicine. But typical AI cannot discover effective biomarkers from real-life clinical trial data. 

Our cloud computing platform provides a powerful and novel AI approach for the discovery of biomarkers, companion diagnostics (CDx), and drug targets from raw, real-life, small-cohort, multi-omic, and noisy clinical data, with label-free (unsupervised) batch effect correction and data harmonization among multiple sites, demographic variables, measurement platforms, and collection protocols.

Our patented technology, based on quantum mechanics, has produced multiple novel oncology biomarkers that have been clinically proven to be the most accurate and precise in peer-reviewed publications.

Let’s partner up to cure the most devastating diseases!

AI/ML

Biotechnology

Health Data

Health Diagnostics

Therapeutics

Prism AI Therapeutics

Prism AI Therapeutics' headquarters in Salt Lake City, United States

Description

People (1)

Jason Friske

Jobs